Email this article Study of matrix metalloproteinases and their tissue inhibitor in patients with ovarian tumors
- Authors: Lactionov K.P.1, Levkina N.V.1, Kushlinsky D.N.1, Hershtein E.S.1
-
Affiliations:
- Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
- Issue: No 2 (2012)
- Pages: 48-54
- Section: GYNECOLOGY. PROBLEM
- Published: 23.05.2012
- URL: https://ojrs.abvpress.ru/ojrs/article/view/99
- DOI: https://doi.org/10.17650/1994-4098-2012-0-2-48-54
- ID: 99
Cite item
Full Text
Abstract
We studied main matrix metalloproteinases (MMP) and their tissue inhibitors in tumors and blood serum of ovarian cancer, benign and borderline tumor patients. We revealed a coordinate increase of MMP-7 tumor expression and serum concentration in ovarian cancer that indicates it’s role as potential serological marker for ovarian cancer.
About the authors
K. P. Lactionov
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
N. V. Levkina
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Author for correspondence.
Email: ya.n-levkina@yandex.ru
Russian Federation
D. N. Kushlinsky
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
E. S. Hershtein
Federal State Budgetary Institution N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, MoscowRussian Federation
References
Supplementary files
